SIGY
PINK Sigyn Therapeutics, Inc.$0.0329 ↓ -0.0022 (-6.35%) Trading Down from the previous close of $0.0351, and at the day’s high of $0.0351
- YTD change
- -78.09%
- vs 20-day SMA
- +4.69%
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
+0.01 (+44.30%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 91.8% away from all-time highs of $0.4000
- SIGY is down 78% since the beginning of the year
- SIGY is down 78% over the past 12 months
- SIGY is up 10% over the past 1 month
SIGY reads neutral: the 12-month move is -98.4%.
- Previous minute
- +$0.0000
- Last hour
- -$0.0022
- Last 5 days
- +13.35%
- vs 8-day SMA
- +3.29%
No alerts for SIGY in the last day.
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Sigyn Therapeutics, Inc. is a development-stage company, which focuses on creating therapeutic solutions that address unmet needs in global health. Its product, Sigyn Therapy, is a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders that are not addressed with approved drug therapies. The company was founded by James A. Joyce and Craig P. Roberts on October 29, 2019 and is headquartered in San Diego, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.